Publications:

Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports

Šimčíková, Daniela D; Heneberg, Petr P

Publication Date: 2019-12-09

Variant appearance in text: PTEN: G129C

PubMed Link: 31819097

Variant Present in the following documents:

• 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8

View BVdb publication page

Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

Oncogene

Steelman, L S LS; Navolanic, P M PM; Sokolosky, M L ML; Taylor, J R JR; Lehmann, B D BD; Chappell, W H WH; Abrams, S L SL; Wong, E W T EW; Stadelman, K M KM; Terrian, D M DM; Leslie, N R NR; Martelli, A M AM; Stivala, F F; Libra, M M; Franklin, R A RA; McCubrey, J A JA

Publication Date: 2008-07-03

Variant appearance in text: PTEN: G129C

PubMed Link: 18332865

Variant Present in the following documents:

• Main text

View BVdb publication page